Using health economic modelling to inform the design and development of an intervention: estimating the justifiable cost of weight loss maintenance in the UK

被引:3
|
作者
Bates, Sarah E. [1 ]
Thomas, Chloe [1 ]
Islam, Nazrul [2 ]
Ahern, Amy L. [3 ]
Breeze, Penny [1 ]
Griffin, Simon [3 ]
Brennan, Alan [1 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit & Epidemiol Studies Unit CTS, Oxford, England
[3] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England
基金
英国惠康基金;
关键词
Health economic modelling; Weight loss maintenance; Behavioural intervention; LIFE-STYLE INTERVENTION; LONG-TERM MAINTENANCE; BODY-MASS INDEX; DIABETES PREVENTION; CARDIOVASCULAR RISK; EXTENDED-CARE; LOSS PROGRAM; MANAGEMENT; OBESITY; ASSOCIATION;
D O I
10.1186/s12889-022-12737-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: There is a need to develop cost-effective weight loss maintenance interventions to prolong the positive impact of weight loss on health outcomes. Conducting pre-trial health economic modelling is recommended to inform the design and development of behavioural interventions. We aimed to use health economic modelling to estimate the maximum cost per-person (justifiable cost) of a cost-effective behavioural weight loss maintenance intervention, given an estimated intervention effect for individuals with: i) a Body Mass Index (BMI) of 28 kg/m(2) or above without diabetes and ii) a diagnosis of type 2 diabetes prescribed a single non-insulin diabetes medication. Methods: The School for Public Health Research Diabetes prevention model was used to estimate the lifetime Quality-adjusted life year (QALY) gains, healthcare costs, and maximum justifiable cost associated with a weight loss maintenance intervention. Based on a meta-analysis, the estimated effect of a weight loss maintenance intervention following a 9 kg weight loss, was a regain of 1.33 kg and 4.38 kg in years one and two respectively compared to greater regain of 2.84 kg and 5.6 kg in the control group. Sensitivity analysis was conducted around the rate of regain, duration of effect and initial weight loss. Results: The justifiable cost for a weight loss maintenance intervention at an ICER of 20,000 pound per QALY was 104.64 pound for an individual with a BMI of 28 or over and 88.14 pound for an individual with type 2 diabetes. Within sensitivity analysis, this varied from 36.42 pound to 203.77 pound for the former, and between 29.98 pound and 173.05 pound for the latter. Conclusions: Researchers developing a weight loss maintenance intervention should consider these maximum justifiable cost estimates and the potential impact of the duration of effect and initial weight loss when designing intervention content and deciding target populations. Future research should consider using the methods demonstrated in this study to use health economic modelling to inform the design and budgetary decisions in the development of a behavioural interventions.
引用
收藏
页数:12
相关论文
共 3 条
  • [1] Using health economic modelling to inform the design and development of an intervention: estimating the justifiable cost of weight loss maintenance in the UK
    Sarah E. Bates
    Chloe Thomas
    Nazrul Islam
    Amy L. Ahern
    Penny Breeze
    Simon Griffin
    Alan Brennan
    [J]. BMC Public Health, 22
  • [2] Using a holistic health approach to achieve weight-loss maintenance: results from the Spirited Life intervention
    Proeschold-Bell, Rae Jean
    Steinberg, Dori M.
    Yao, Jia
    Eagle, David E.
    Smith, Timothy W.
    Cai, Grace Y.
    Turner, Elizabeth L.
    [J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2020, 10 (01) : 223 - 233
  • [3] The WORD (Wholeness, Oneness, Righteousness, Deliverance): design of a randomized controlled trial testing the effectiveness of an evidence-based weight loss and maintenance intervention translated for a faith-based, rural, African American population using a community-based participatory approach
    Yeary, Karen Hye-Cheon Kim
    Cornell, Carol E.
    Prewitt, Elaine
    Bursac, Zoran
    Tilford, J. Mick
    Turner, Jerome
    Eddings, Kenya
    Love, ShaRhonda
    Whittington, Emily
    Harris, Kimberly
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 40 : 63 - 73